Researchers have taken detailed images and measurements of the morphing structure of a brain protein thought to play a role in Parkinson's disease, information that could aid the development of medications to treat the condition.

Researchers from the University of Wisconsin-Milwaukee (UWM) have identified mechanisms in the brain responsible for regulating cocaine-seeking behavior, providing an avenue for drug development that could greatly reduce the high relapse rate among cocaine addicts.

A quicker and cheaper technique to scan molecular databases developed at the Department of Energy's Oak Ridge National Laboratory could put scientists on the fast track to developing new drug treatments

Aptuit Inc., an international contract research organization whose facilities span North America, Europe, India and Asia Pacific, delivers client support from preclinical studies to commercial drug product launches.

Contract labs perform scientific research and testing on one or more components of projects for external clients. Contracts can last anywhere from only a few weeks for a single, specific task to many years for extended projects. Taylor Technology Inc., a subsidiary of PharmaNet Development Group Inc., is a drug development contract research organization focused on bioanalysis, the measurement of potentially new chemicals or molecular entities (new treatments) in biological samples.

The FDA has increased its focus on modernizing the regulation of pharmaceutical manufacturing and drug product quality. As a result, innovative pharmaceutical companies are re-examining whether traditional drug development and commercialization processes are sufficient.